Workflow Times and Outcomes in Patients Triaged for a Suspected Severe Stroke.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
12 2022
Historique:
revised: 21 07 2022
received: 05 05 2022
accepted: 18 08 2022
pubmed: 3 9 2022
medline: 19 11 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Current recommendations for regional stroke destination suggest that patients with severe acute stroke in non-urban areas should be triaged based on the estimated transport time to a referral thrombectomy-capable center. We performed a post hoc analysis to evaluate the association of pre-hospital workflow times with neurological outcomes in patients included in the RACECAT trial. Workflow times evaluated were known or could be estimated before transport allocation. Primary outcome was the shift analysis on the modified Rankin score at 90 days. Among the 1,369 patients included, the median time from onset to emergency medical service (EMS) evaluation, the estimated transport time to a thrombectomy-capable center and local stroke center, and the estimated transfer time between centers were 65 minutes (interquartile ratio [IQR] = 43-138), 61 minutes (IQR = 36-80), 17 minutes (IQR = 9-27), and 62 minutes (IQR = 36-73), respectively. Longer time intervals from stroke onset to EMS evaluation were associated with higher odds of disability at 90 days in the local stroke center group (adjusted common odds ratio (acOR) for each 30-minute increment = 1.03, 95% confidence interval [CI] = 1.01-1.06), with no association in the thrombectomy-capable center group (acOR for each 30-minute increment = 1.01, 95% CI = 0.98-1.01, p We found a significant heterogeneity in the association between initial transport destination and neurological outcomes according to the elapse of time between the stroke onset and the EMS evaluation (ClinicalTrials.gov: NCT02795962). ANN NEUROL 2022;92:931-942.

Identifiants

pubmed: 36053966
doi: 10.1002/ana.26489
doi:

Banques de données

ClinicalTrials.gov
['NCT02795962']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

931-942

Informations de copyright

© 2022 American Neurological Association.

Références

Saver JL. Time is brain-quantified. Stroke 2006;37:263-266.
Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016;316:1279-1288.
Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-1935.
Jahan R, Saver JL, Schwamm LH, et al. Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice. JAMA 2019;322:252-263.
McTaggart RA, Yaghi S, Cutting SM, et al. Association of a Primary Stroke Center Protocol for suspected stroke by large-vessel occlusion with efficiency of care and patient outcomes. JAMA Neurol 2017;74:793-800.
Perez de la Ossa N, Abilleira S, Dorado L, et al. Access to endovascular treatment in remote areas: analysis of the reperfusion treatment registry of Catalonia. Stroke 2016;47:1381-1384.
Menon BK, Xu H, Cox M, et al. Components and trends in door to treatment times for endovascular therapy in get with the guidelines-stroke hospitals. Circulation 2019;139:169-179.
Duvekot MHC, Venema E, Rozeman AD, et al. Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study. Lancet Neurol 2021;20:213-221.
Fassbender K, Walter S, Grunwald IQ, et al. Prehospital stroke management in the thrombectomy era. Lancet Neurol 2020;19:601-610.
Abilleira S, Perez de la Ossa N, Jimenez X, et al. Transfer to the local stroke center versus direct transfer to endovascular Center of Acute Stroke Patients with suspected large vessel occlusion in the Catalan territory (RACECAT): study protocol of a cluster randomized within a cohort trial. Int J Stroke 2019;14:734-744.
Froehler MT, Saver JL, Zaidat OO, et al. Interhospital transfer before Thrombectomy is associated with delayed treatment and worse outcome in the STRATIS registry (systematic evaluation of patients treated with Neurothrombectomy devices for acute ischemic stroke). Circulation 2017;136:2311-2321.
Holodinsky JK, Williamson TS, Demchuk AM, et al. Modeling stroke patient transport for all patients with suspected large-vessel occlusion. JAMA Neurol 2018;75:1477-1486.
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early Management of Patients with Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46-e110.
Jauch EC, Schwamm LH, Panagos PD, et al. Recommendations for Regional Stroke Destination Plans in Rural, Suburban, and Urban Communities From the Prehospital Stroke System of Care Consensus Conference: A Consensus Statement From the American Academy of Neurology, American Heart Association/American Stroke Association, American Society of Neuroradiology, National Association of EMS Physicians, National Association of State EMS Officials, Society of NeuroInterventional Surgery, and Society of Vascular and Interventional Neurology: Endorsed by the Neurocritical Care Society. Stroke 2021;52:e133-e152.
Perez de la Ossa N, Carrera D, Gorchs M, et al. Design and validation of a prehospital stroke scale to predict large arterial occlusion: the rapid arterial occlusion evaluation scale. Stroke 2014;45:87-91.
Perez de la Ossa N, Abilleira S, Jovin T, et al. Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas. JAMA 2022;327:1-13.
Caplan LR. Primary stroke centers vs comprehensive stroke centers with interventional capabilities: which is better for a patient with suspected stroke? JAMA Neurol 2017;74:504-506.
Venema E, Groot AE, Lingsma HF, et al. Effect of Interhospital transfer on endovascular treatment for acute ischemic stroke. Stroke 2019;50:923-930.
Gorelick PB. Primary and comprehensive stroke centers: history, value and certification criteria. J Stroke 2013;15:78-89.
Yeo LL, Paliwal P, Teoh HL, et al. Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke. JAMA Neurol 2013;70:353-358.
Goyal M, Jadhav AP, Bonafe A, et al. Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: results from the SWIFT PRIME randomized controlled trial. Radiology 2016;279:888-897.
Ribo M, Alvarez-Sabin J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006;37:1000-1004.
Goyal M, Almekhlafi M, Dippel DW, et al. Rapid Alteplase administration improves functional outcomes in patients with stroke due to large vessel occlusions. Stroke 2019;50:645-651.
Muchada M, Rodriguez-Luna D, Pagola J, et al. Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2014;45:2734-2738.
Xu Y, Parikh NS, Jiao B, et al. Decision analysis model for prehospital triage of patients with acute stroke. Stroke 2019;50:970-977.
Acker JE 3rd, Pancioli AM, Crocco TJ, et al. Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association expert panel on emergency medical services systems and the stroke council. Stroke 2007;38:3097-3115.
Adeoye O, Nystrom KV, Yavagal DR, et al. Recommendations for the establishment of stroke Systems of Care: a 2019 update. Stroke 2019;50:e187-e210.
Fassbender K, Balucani C, Walter S, et al. Streamlining of prehospital stroke management: the golden hour. Lancet Neurol 2013;12:585-596.
Pulvers JN, Watson JDG. If time is brain where is the improvement in prehospital time after stroke? Front Neurol 2017;8:617.
Gu HQ, Rao ZZ, Yang X, et al. Use of emergency medical services and timely treatment among ischemic stroke. Stroke 2019;50:1013-1016.
Audebert H, Fassbender K, Hussain MS, et al. The PRE-hospital stroke treatment organization. Int J Stroke 2017;12:932-940.
Soto-Camara R, Gonzalez-Bernal J, Aguilar-Parra JM, et al. Factors related to prehospital time in caring for patients with stroke. Emergencias 2021;33:454-463.
Fassbender K, Grotta JC, Walter S, et al. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol 2017;16:227-237.
Ictus. PD. Newsletter CICAT. Stroke Code Registry Catalonia. https://app.powerbi.com/view?r=eyJrIjoiYmUwYmM5MjYtMWJlNy00NDdiLTljNGMtYzU5N2Y3MjFkYzU2IiwidCI6IjNiOTQyN2RjLWQzMGUtNDNiYy04YzA2LWZmNzI1MzY3NmZlYyIsImMiOjh9. https://app.powerbi.com/view?r=eyJrIjoiYmUwYmM5MjYtMWJlNy00NDdiLTljNGMtYzU5N2Y3MjFkYzU2IiwidCI6IjNiOTQyN2RjLWQzMGUtNDNiYy04YzA2LWZmNzI1MzY3NmZlYyIsImMiOjh9. Accessed October 6, 2021.
Mack WJ, Mocco J, Hirsch JA, et al. Thrombectomy stroke centers: the current threat to regionalizing stroke care. J Neurointerv Surg 2018;10:99-101.
Baker DW, Schmaltz S, Kolbusz K, et al. Differences in performance on quality measures for thrombectomy-capable stroke centers compared with comprehensive stroke centers in 2019 to 2020. Stroke 2022;e000302.
Waqas M, Tutino VM, Cappuzzo JM, et al. Stroke thrombectomy volume, rather than stroke center accreditation status of hospitals, is associated with mortality and discharge disposition. J Neurointerv Surg 2022.
Yu CY, Panagos PD, Kansagra AP. Travel time and distance for bypass and non-bypass routing of stroke patients in the USA. J Neurointerv Surg 2022;neurintsurg-2022-018787.

Auteurs

Álvaro García-Tornel (Á)

Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Laia Seró (L)

Department of Neurology, Hospital Universitari Joan XXIII, Tarragona, Spain.

Xabier Urra (X)

Stroke Unit, Hospital Clínic, Barcelona, Spain.

Pere Cardona (P)

Stroke Unit, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Spain.

Josep Zaragoza (J)

Department of Neurology, Hospital Verge de la Cinta, Tortosa, Spain.

Jerzy Krupinski (J)

Department of Neurology, Hospital Mútua Terrassa, Terrassa, Spain.

Manuel Gómez-Choco (M)

Department of Neurology, Complex Hospitalari Hospital Moisés Broggi, Sant Joan Despí, Spain.

Natalia Mas Sala (NM)

Department of Neurology, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain.

Esther Catena (E)

Department of Neurology, Consorci Sanitari Alt Penedès-Garraf, Vilafranca del Penedès, Spain.

Ernest Palomeras (E)

Department of Neurology, Hospital Mataró, Mataró, Spain.

Joaquin Serena (J)

Stroke Unit, Hospital Universitari Josep Trueta, Girona, Spain.

Maria Hernandez-Perez (M)

Stroke Unit, Hospital Germans Trias i Pujol, Badalona, Spain.

Sandra Boned (S)

Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Marta Olivé-Gadea (M)

Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Manuel Requena (M)

Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Department of Interventional Neuroradiology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Marian Muchada (M)

Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Alejandro Tomasello (A)

Department of Interventional Neuroradiology, Hospital Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Carlos A Molina (CA)

Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Mercè Salvat-Plana (M)

Stroke Program, Catalan Health Department, Agency for Health Quality and Assessment of Catalonia (AQuAS), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Mar Escudero (M)

Sistema d'Emergències Mèdiques, Barcelona, Spain.

Xavier Jimenez (X)

Sistema d'Emergències Mèdiques, Barcelona, Spain.

Antoni Davalos (A)

Stroke Unit, Hospital Germans Trias i Pujol, Badalona, Spain.

Tudor G Jovin (TG)

Neurological Institute, Cooper University Hospital, Camden, NJ.

Francesc Purroy (F)

Stroke Unit, Department of Neurology, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain.

Sonia Abilleira (S)

Stroke Program, Catalan Health Department, Agency for Health Quality and Assessment of Catalonia (AQuAS), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Marc Ribo (M)

Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Natalia Perez de la Ossa (NP)

Stroke Unit, Hospital Germans Trias i Pujol, Badalona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH